Kalobios Pharmaceuticals, Inc.

Get Full Access

Description

  • KaloBios is a biopharmaceutical company dedicated to helping the lives of patients with innovative therapies. Our mission is to improve the lives of cancer patients with innovative, Humaneered®, monoclonal antibodies.KaloBios' Humaneered® antibodies are next generation, customized antibodies designed to overcome challenges limiting today's marketed antibody products. Using our expertise, our antibodies are customized to enhance a desired effect or reduce a possible undesired effect.Our pipeline is comprised of Humaneered® antibodies. These antibodies are being investigated in clinical development programs focused on treating cancer:KB004 (anti-EphA3) Humaneered® mAb to treat patients with hematologic malignancies, solid tumors, and their stem cells; currently enrolling patients with myelofibrosis and myelodysplastic syndrome in the companys Phase 2 expansion portion of its Phase 1/2 clinical trial in hematologic malignancies; andKB003 (anti-GM-CSF) Humaneered® mAb that KaloBios intends to evaluate in oncology indications where GM-CSF may play a key role in such indications as chronic myelomonocytic leukemia (CMML). KaloBios intends to commence clinical evaluation of KB003 in this patient population beginning in the second half of 2015.We use a patient-targeted approach utilizing or developing a screen or diagnostic method to identify those patients most likely to benefit from our treatments.
  • location

    Headquarters:442 Littlefield Avenue , South San Francisco, California, United States

    More
  • Kalobios Pharmaceuticals, Inc. phone

    Phone Number: +1 650-243-3120

  • Kalobios Pharmaceuticals, Inc. website

    Website: https://www.kalobios.com

  • Kalobios Pharmaceuticals, Inc. employees

    Employees:11

  • Kalobios Pharmaceuticals, Inc. revenue

    Revenue:$10 - 50M

  • Kalobios Pharmaceuticals, Inc. legal name

    Legal Name:Kalobios Pharmaceuticals, Inc.

  • Kalobios Pharmaceuticals, Inc.'s Social Media

    Kalobios Pharmaceuticals, Inc. linkedin
  • done Is this data correct?
  • |  NAICS Code: 541713  |

    Show More
Person level website identification

Director Facilities for Kalobios Pharmaceuticals, Inc.

Gil De Vincenzi

Director Facilities

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Gil De Vincenzi

Director Facilities

Nicholas Williams

Director Of Business Development

Mike Flashner

Clinical Program Director

Edmond Mok

Senior Director And Controller

Jennifer Bruce

Manager

Frequently Asked Questions regarding Kalobios Pharmaceuticals, Inc.

  • Where are Kalobios Pharmaceuticals, Inc.'s Headquarters?

    Kalobios Pharmaceuticals, Inc.'s Headquarters are in 442 Littlefield Avenue ,South San Francisco,California,United States

  • What is Kalobios Pharmaceuticals, Inc.'s phone number?

    Kalobios Pharmaceuticals, Inc.'s phone number is +1 650-243-3120

  • What is Kalobios Pharmaceuticals, Inc.'s official website?

    Kalobios Pharmaceuticals, Inc.'s official website is https://www.kalobios.com

  • What is Kalobios Pharmaceuticals, Inc.'s Revenue?

    Kalobios Pharmaceuticals, Inc.'s revenue is $10 - 50M

  • What is Kalobios Pharmaceuticals, Inc.'s NAICS code?

    Kalobios Pharmaceuticals, Inc.'s NAICS code is 541713

  • How many employees are working in Kalobios Pharmaceuticals, Inc.

    Kalobios Pharmaceuticals, Inc. has 11 employees

  • What is Kalobios Pharmaceuticals, Inc.'s Industry?

    Kalobios Pharmaceuticals, Inc. is in the industry of Biotechnology

  • Who is Kalobios Pharmaceuticals, Inc.'s Director Facilities?

    Kalobios Pharmaceuticals, Inc.'s Director Facilities is Gil De Vincenzi

Company Directory